Björn Chapuy

25PUBLICATIONS
243CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 18, 2026
Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.

|Apr 23, 2026
Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis.

|Oct 22, 2025
Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3×CD20 bispecific T-cell engagers.

Giulia Magno, Kai Rejeski, Giulia Rappa

|Oct 16, 2025
A CD22-specific T-cell receptor enables effective adoptive T-cell therapy for B-cell malignancies.

Simone Rhein, Neşe Çakmak-Görür, Corinna Grunert

|Aug 04, 2025
Discovery of molecularly-informed therapeutic strategies for mature T-cell leukemias and lymphomas.

Nicole Schmidt, Kevin Kornrumpf, Lena Ries

|Jul 12, 2025
Clinical Predictors and Recurrence Characteristics Following Radiotherapy for Primary Central Nervous System Lymphoma: A Retrospective Cohort Study.

Jan Carl Bigge, Stephanie Bendrich, Hannes Treiber

Pageof 5

Frequent Collaborators

5 joint publications

Bastian von Tresckow

5 joint publications

Ulrich Keller

5 joint publications

Evgenii Shumilov

5 joint publications

Kamil Bojarczuk